Vascular stent or graft coated or impregnated with protein tyrosine kinase inhibitors and method of using same
CA 2464093 A1 · Owner: Griffin, Michael Orrin · Inventors: Stoker, Scott William; Griffin, Michael Orrin; Wolff, Matthew R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed is a device, such as a cardiovascular stent autologous , venous/arterial graft, prosthetic venous/arterial graft vascular catheter, or , vascular shunt for stenting a blood vessel. The device has coated thereon adsorbed thereto, impregnated therein, or covalently or ionically bonded thereto an amount of a protein tyrosine kinase inhibitor. The protein tyrosine kinase inhibitor proliferation of vascular smooth muscle cells in an area within a blood vessel immediately adjacent to and/or proximal to the device while simultaneously not inhibiting the proliferation of vascular intimal cells. A corresponding method of using the device to stent blood vessels is also disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 25, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 25, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 25, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.